Skip to main content

Advertisement

Log in

Pronounced Coronary Arteriosclerosis in Cirrhosis: Influence on Cardiac Function and Survival?

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

The relation between excessive alcohol consumption and coronary arteriosclerosis has remained controversial. The etiology of cirrhosis has been considered a substantial risk factor for development of arteriosclerotic lesions. The coronary artery calcium-score derived from coronary CT angiography is a robust marker of coronary arteriosclerosis.

Aims

To study the burden of coronary arteriosclerosis in cirrhotic patients of various etiologies and association to cardiac dysfunction and survival.

Methods

Fifty-seven patients with cirrhosis without cardiovascular disease underwent coronary CT angiography, tissue Doppler echocardiography, electrocardiogram and registration of clinical and biochemical characteristics.

Results

In patients with cirrhosis the median coronary artery calcium-score was increased in comparison with age and race-adjusted healthy reference values (men: 328 vs. 9 HU and women: 136 vs. 0 HU; p < 0.001). Moreover, the coronary artery calcium-score in alcohol-related cirrhosis was significantly higher than in nonalcohol-related cirrhosis (362 vs. 46 HU, p < 0.001). Coronary artery calcium-score correlated with age (p = 0.002) but not with established cardiovascular risk factors including smoking, type 2 diabetes, hypertension, gender, or hypercholesterolemia. Coronary artery calcium-score was associated with diastolic dysfunction, lateral e´ (p = 0.025), but not with other markers of cardiac dysfunction. During a median follow-up of 25 months 12 patients (21%) died but coronary artery calcium-score was not associated with survival.

Conclusions

Coronary arteriosclerosis was particular extensive in patients with alcoholic cirrhosis. However, the current results suggest that coronary arteriosclerosis only have limited influence on cardiac function and survival. Surprisingly, no other established risk factors apart from age seemed to interfere with coronary arteriosclerosis in cirrhotic patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Andrews J, Puri R, Kataoka Y, Nicholls SJ, Psaltis PJ. Therapeutic modulation of the natural history of coronary atherosclerosis: lessons learned from serial imaging studies. Cardiovasc Diagn Ther. 2016;6:282–303.

    Article  PubMed  PubMed Central  Google Scholar 

  2. An J, Shim JH, Kim S-O, et al. Prevalence and prediction of coronary artery disease in patients with liver cirrhosis: a registry-based matched case-control study. Circulation. 2014;130:1353–1362.

    Article  PubMed  Google Scholar 

  3. Kianoush S, Al Rifai M, Cainzos-Achirica M, et al. An update on the utility of coronary artery calcium scoring for coronary heart disease and cardiovascular disease risk prediction. Curr Atheroscler Rep. 2016;18:13.

    Article  PubMed  Google Scholar 

  4. Voulgaris T, Sevastianos VA. Atherosclerosis as extrahepatic manifestation of chronic infection with hepatitis C virus. Hepat Res Treat. 2016;2016:7629318.

    PubMed  PubMed Central  Google Scholar 

  5. Kokolis S, Marmur JD, Clark LT, et al. Effects of alcoholism on coronary artery disease and left ventricular dysfunction in male veterans. J Invasive Cardiol. 2006;18:304–307.

    PubMed  Google Scholar 

  6. Kalaitzakis E, Björnsson E. Coronary artery disease in liver cirrhosis: does the aetiology of liver disease matter? J Hepatol. 2009;51:962–963.

    Article  PubMed  Google Scholar 

  7. Møller S, Wiese S, Halgreen H, Hove JD. Diastolic dysfunction in cirrhosis. Heart Fail Rev. 2016;21:599–610.

    Article  PubMed  Google Scholar 

  8. Møller S, Bernardi M. Interactions of the heart and the liver. Eur Heart J. 2013;34:2804–2811.

    Article  PubMed  Google Scholar 

  9. Bittencourt MS, Hulten E, Ghoshhajra B, et al. Prognostic value of nonobstructive and obstructive coronary artery disease detected by coronary computed tomography angiography to identify cardiovascular events. Circ Cardiovasc Imaging. 2014;7:282–291.

    Article  PubMed  Google Scholar 

  10. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15:827–832.

    Article  CAS  PubMed  Google Scholar 

  11. Nakanishi R, Li D, Blaha MJ, et al. The relationship between coronary artery calcium score and the long-term mortality among patients with minimal or absent coronary artery risk factors. Int J Cardiol. 2015;185:275–281.

    Article  PubMed  Google Scholar 

  12. Nasir K, Rubin J, Blaha MJ, et al. Interplay of coronary artery calcification and traditional risk factors for the prediction of all-cause mortality in asymptomatic individuals. Circ Cardiovasc Imaging. 2012;5:467–473.

    Article  PubMed  Google Scholar 

  13. Agatston AS, Janowitz WR, Kaplan G, Gasso J, Hildner F, Viamonte M. Ultrafast computed tomography-detected coronary calcium reflects the angiographic extent of coronary arterial atherosclerosis. Am J Cardiol. 1994;74:1272–1274.

    Article  CAS  PubMed  Google Scholar 

  14. Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Hear J Cardiovasc Imaging. 2015;16:233–271.

    Article  Google Scholar 

  15. Pletcher MJ, Sibley CT, Pignone M, Vittinghoff E, Greenland P. Interpretation of the coronary artery calcium score in combination with conventional cardiovascular risk factors: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2013;128:1076–1084.

    Article  PubMed  Google Scholar 

  16. Kalaitzakis E, Rosengren A, Skommevik T, Björnsson E. Coronary artery disease in patients with liver cirrhosis. Dig Dis Sci. 2010;55:467–475.

    Article  PubMed  Google Scholar 

  17. Keeling AN, Flaherty JD, Davarpanah AH, et al. Coronary multidetector computed tomographic angiography to evaluate coronary artery disease in liver transplant candidates: methods, feasibility and initial experience. J Cardiovasc Med. 2011;12:460–468.

    Article  Google Scholar 

  18. Kemmer N, Case J, Chandna S, Neff GW. The role of coronary calcium score in the risk assessment of liver transplant candidates. Transplant Proc. 2014;46:230–233.

    Article  CAS  PubMed  Google Scholar 

  19. Kawakami M, Koda M, Murawaki Y. The prevalence of atherosclerosis in cirrhotic patients: assessment of two aspects of atherosis and sclerosis. Hepatol Res. 2007;37:152–157.

    Article  PubMed  Google Scholar 

  20. Berzigotti A, Bonfiglioli A, Muscari A, et al. Reduced prevalence of ischemic events and abnormal supraortic flow patterns in patients with liver cirrhosis. Liver Int. 2005;25:331–336.

    Article  PubMed  Google Scholar 

  21. Marchesini G, Ronchi M, Forlani G, et al. Cardiovascular disease in cirrhosis. A point-prevalence study in relation to glucose tolerance. Am J Gastroenterol. 1999;94:655–662.

    CAS  PubMed  Google Scholar 

  22. Kazankov K, Munk K, Øvrehus KA, et al. High burden of coronary atherosclerosis in patients with cirrhosis. Eur J Clin Invest. 2017;47:565–573.

    Article  PubMed  Google Scholar 

  23. Gologorsky E, Pretto EA, Fukazawa K. Coronary artery disease and its risk factors in patients presenting for liver transplantation. J Clin Anesth.. 2013;25:618–623.

    Article  PubMed  Google Scholar 

  24. Kadayifci A, Tan V, Ursell PC, Merriman RB, Bass NM. Clinical and pathologic risk factors for atherosclerosis in cirrhosis: a comparison between NASH-related cirrhosis and cirrhosis due to other aetiologies. J Hepatol. 2008;49:595–599.

    Article  PubMed  Google Scholar 

  25. McAvoy NC, Kochar N, McKillop G, Newby DE, Hayes PC. Prevalence of coronary artery calcification in patients undergoing assessment for orthotopic liver transplantation. Liver Transpl. 2008;14:1725–1731.

    Article  PubMed  Google Scholar 

  26. Plotkin JS, Scott VL, Pinna A, Dobsch BP, De Wolf AM, Kang Y. Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation. Liver Transplant Surg. 1996;2:426–430.

    Article  CAS  Google Scholar 

  27. Tiukinhoy-Laing SD, Rossi JS, Bayram M, et al. Cardiac hemodynamic and coronary angiographic characteristics of patients being evaluated for liver transplantation. Am J Cardiol. 2006;98:178–181.

    Article  PubMed  Google Scholar 

  28. Cassagneau P, Jacquier A, Giorgi R, et al. Prognostic value of preoperative coronary computed tomography angiography in patients treated by orthotopic liver transplantation. Eur J Gastroenterol Hepatol. 2012;24:558–562.

    Article  PubMed  Google Scholar 

  29. Patel S, Kiefer TL, Ahmed A, et al. Comparison of the frequency of coronary artery disease in alcohol-related versus non-alcohol-related endstage liver disease. Am J Cardiol. 2011;108:1552–1555.

    Article  PubMed  Google Scholar 

  30. Carey WD, Dumot JA, Pimentel RR, et al. The prevalence of coronary artery disease in liver transplant candidates over age 50. Transplantation. 1995;59:859–864.

    Article  CAS  PubMed  Google Scholar 

  31. Burroughs AK, Sabin CA, Rolles K, et al. 3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome. Lancet. 2006;367:225–232.

    Article  PubMed  Google Scholar 

  32. Safadi A, Homsi M, Maskoun W, et al. Perioperative risk predictors of cardiac outcomes in patients undergoing liver transplantation surgery. Circulation. 2009;120:1189–1194.

    Article  PubMed  Google Scholar 

  33. Thomsen JL. Atherosclerosis in alcoholics. Forensic Sci Int. 1995;75:121–131.

    Article  CAS  PubMed  Google Scholar 

  34. Howell WL, Manion WC. The low incidence of myocardial infarction in patients with portal cirrhosis of the liver: a review of 639 cases of cirrhosis of the liver from 17,731 autopsies. Am Heart J. 1960;60:341–344.

    Article  CAS  PubMed  Google Scholar 

  35. Malyutina S, Bobak M, Kurilovitch S, et al. Relation between heavy and binge drinking and all-cause and cardiovascular mortality in Novosibirsk, Russia: a prospective cohort study. Lancet. 2002;360:1448–1454.

    Article  PubMed  Google Scholar 

  36. Agarwal DP. Cardioprotective effects of light-moderate consumption of alcohol: a review of putative mechanisms. Alcohol Alcohol. 2002;37:409–415.

    Article  CAS  PubMed  Google Scholar 

  37. Grønbaek M. The positive and negative health effects of alcohol- and the public health implications. J Intern Med. 2009;265:407–420.

    Article  PubMed  Google Scholar 

  38. Cho I-J, Chang H-J, Park H-B, et al. Aortic calcification is associated with arterial stiffening, left ventricular hypertrophy, and diastolic dysfunction in elderly male patients with hypertension. J Hypertens. 2015;33:1633–1641.

    Article  CAS  PubMed  Google Scholar 

  39. Hickler RB. Aortic and large artery stiffness: current methodology and clinical correlations. Clin Cardiol.. 1990;13:317–322.

    Article  CAS  PubMed  Google Scholar 

  40. Ruiz-del-Árbol L, Serradilla R. Cirrhotic cardiomyopathy. World J Gastroenterol. 2015;21:11502–11521.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Kiszka-Kanowitz M, Henriksen JH, Møller S, Bendtsen F. Blood volume distribution in patients with cirrhosis: aspects of the dual-head gamma-camera technique. J Hepatol. 2001;35:605–612.

    Article  CAS  PubMed  Google Scholar 

  42. Wiese S, Hove JD, Bendtsen F, Møller S. Cirrhotic cardiomyopathy: pathogenesis and clinical relevance. Nat Rev Gastroenterol Hepatol. 2013;11:177–186.

    Article  PubMed  Google Scholar 

  43. Sørensen HT, Thulstrup AM, Mellemkjar L, et al. Long-term survival and cause-specific mortality in patients with cirrhosis of the liver: a nationwide cohort study in Denmark. J Clin Epidemiol. 2003;56:88–93.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We sincerely thank the staff at Centre for Functional and Diagnostic Imaging and Research, Hvidovre University Hospital for the effort. We thank Allan Poulsen and Hanne Halgreen for their impressive help with the echocardiography measurements and we also thank laboratory technician Katrine Lyngby for her excellent assistance. This project has received financial support and funds from Novo Nordisk Foundation and Amager Hvidovre University Hospital Research Foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Karen V. Danielsen.

Ethics declarations

Conflict of interest

None of the authors had any personal or financial conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Danielsen, K.V., Wiese, S., Hove, J. et al. Pronounced Coronary Arteriosclerosis in Cirrhosis: Influence on Cardiac Function and Survival?. Dig Dis Sci 63, 1355–1362 (2018). https://doi.org/10.1007/s10620-018-5006-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-018-5006-7

Keywords

Navigation